vs
Side-by-side financial comparison of COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
COGENT COMMUNICATIONS HOLDINGS, INC. is the larger business by last-quarter revenue ($240.5M vs $168.4M, roughly 1.4× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -4.7%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -4.9%).
Cogent Communications Holdings, Inc. is a multinational internet service provider based in the United States. Cogent's primary services consist of Internet access and data transport, offered on a fiber optic, IP data-only network, along with colocation in data centers.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
CCOI vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $240.5M | $168.4M |
| Net Profit | $-30.8M | — |
| Gross Margin | 46.6% | — |
| Operating Margin | -4.7% | 50.6% |
| Net Margin | -12.8% | — |
| Revenue YoY | -4.7% | 143.7% |
| Net Profit YoY | 28.9% | — |
| EPS (diluted) | $-0.63 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $240.5M | $168.4M | ||
| Q3 25 | $241.9M | $87.3M | ||
| Q2 25 | $246.2M | $82.4M | ||
| Q1 25 | $247.0M | $65.0M | ||
| Q4 24 | $252.3M | $69.1M | ||
| Q3 24 | $257.2M | $51.6M | ||
| Q2 24 | $260.4M | $73.8M | ||
| Q1 24 | $266.2M | $137.7M |
| Q4 25 | $-30.8M | — | ||
| Q3 25 | $-41.5M | $-31.3M | ||
| Q2 25 | $-57.8M | $-12.7M | ||
| Q1 25 | $-52.0M | $-40.5M | ||
| Q4 24 | $-43.3M | — | ||
| Q3 24 | $-63.1M | $-29.5M | ||
| Q2 24 | $-32.3M | $-61.9M | ||
| Q1 24 | $-65.3M | $61.0M |
| Q4 25 | 46.6% | — | ||
| Q3 25 | 45.6% | — | ||
| Q2 25 | 44.2% | — | ||
| Q1 25 | 44.4% | — | ||
| Q4 24 | 38.5% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 40.0% | — | ||
| Q1 24 | 36.5% | — |
| Q4 25 | -4.7% | 50.6% | ||
| Q3 25 | -7.5% | -11.4% | ||
| Q2 25 | -12.8% | 8.6% | ||
| Q1 25 | -16.3% | -34.0% | ||
| Q4 24 | -13.2% | -6.4% | ||
| Q3 24 | -22.5% | -31.0% | ||
| Q2 24 | -18.1% | 3.5% | ||
| Q1 24 | -22.3% | 52.5% |
| Q4 25 | -12.8% | — | ||
| Q3 25 | -17.2% | -35.9% | ||
| Q2 25 | -23.5% | -15.4% | ||
| Q1 25 | -21.1% | -62.2% | ||
| Q4 24 | -17.2% | — | ||
| Q3 24 | -24.5% | -57.2% | ||
| Q2 24 | -12.4% | -83.9% | ||
| Q1 24 | -24.5% | 44.3% |
| Q4 25 | $-0.63 | $0.32 | ||
| Q3 25 | $-0.87 | $-0.16 | ||
| Q2 25 | $-1.21 | $-0.06 | ||
| Q1 25 | $-1.09 | $-0.21 | ||
| Q4 24 | $-0.89 | $-0.14 | ||
| Q3 24 | $-1.33 | $-0.15 | ||
| Q2 24 | $-0.68 | $-0.33 | ||
| Q1 24 | $-1.38 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $148.5M | $167.9M |
| Total DebtLower is stronger | $1.7B | — |
| Stockholders' EquityBook value | $-63.8M | $-302.0M |
| Total Assets | $3.1B | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $148.5M | $167.9M | ||
| Q3 25 | $147.1M | $92.4M | ||
| Q2 25 | $213.7M | $86.1M | ||
| Q1 25 | $153.8M | $114.6M | ||
| Q4 24 | $198.5M | $144.8M | ||
| Q3 24 | $279.2M | $144.7M | ||
| Q2 24 | $384.4M | $189.3M | ||
| Q1 24 | $118.4M | $226.6M |
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-63.8M | $-302.0M | ||
| Q3 25 | $-39.2M | $-451.4M | ||
| Q2 25 | $46.7M | $-433.5M | ||
| Q1 25 | $142.8M | $-426.2M | ||
| Q4 24 | $222.8M | $-388.7M | ||
| Q3 24 | $323.6M | $-370.2M | ||
| Q2 24 | $415.5M | $-344.2M | ||
| Q1 24 | $500.6M | $-294.3M |
| Q4 25 | $3.1B | $465.9M | ||
| Q3 25 | $3.1B | $364.0M | ||
| Q2 25 | $3.3B | $347.1M | ||
| Q1 25 | $3.1B | $324.0M | ||
| Q4 24 | $3.2B | $343.8M | ||
| Q3 24 | $3.2B | $314.1M | ||
| Q2 24 | $3.3B | $352.3M | ||
| Q1 24 | $3.1B | $373.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.53× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $45.2M |
| Free Cash FlowOCF − Capex | $-43.0M | — |
| FCF MarginFCF / Revenue | -17.9% | — |
| Capex IntensityCapex / Revenue | 15.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-198.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $45.2M | ||
| Q3 25 | $3.1M | $-4.3M | ||
| Q2 25 | $-44.0M | $-31.4M | ||
| Q1 25 | $36.4M | $-22.6M | ||
| Q4 24 | $14.5M | $-35.0M | ||
| Q3 24 | $-20.2M | $-35.3M | ||
| Q2 24 | $-22.2M | $-7.2M | ||
| Q1 24 | $19.2M | $53.8M |
| Q4 25 | $-43.0M | — | ||
| Q3 25 | $-33.1M | — | ||
| Q2 25 | $-100.2M | — | ||
| Q1 25 | $-21.7M | — | ||
| Q4 24 | $-31.6M | — | ||
| Q3 24 | $-79.5M | $-35.5M | ||
| Q2 24 | $-70.9M | $-7.3M | ||
| Q1 24 | $-21.7M | $53.8M |
| Q4 25 | -17.9% | — | ||
| Q3 25 | -13.7% | — | ||
| Q2 25 | -40.7% | — | ||
| Q1 25 | -8.8% | — | ||
| Q4 24 | -12.5% | — | ||
| Q3 24 | -30.9% | -68.7% | ||
| Q2 24 | -27.2% | -9.9% | ||
| Q1 24 | -8.1% | 39.0% |
| Q4 25 | 15.4% | 0.0% | ||
| Q3 25 | 15.0% | 0.0% | ||
| Q2 25 | 22.8% | 0.0% | ||
| Q1 25 | 23.5% | 0.0% | ||
| Q4 24 | 18.3% | 0.0% | ||
| Q3 24 | 23.0% | 0.3% | ||
| Q2 24 | 18.7% | 0.1% | ||
| Q1 24 | 15.4% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCOI
Segment breakdown not available.
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
